name: CERAMIDE 1 5 mg in 1 g / TITANIUM DIOXIDE 50 mg in 1 g / OCTOCRYLENE 20 meq in 1 g / CERAMIDE 3 5 mg in 1 g / CERAMIDE 6 II 5 mg in 1 g / ZINC OXIDE 90 mg in 1 g / NIACINAMIDE 40 mg in 1 g / HOMOSALATE 100 mg in 1 g TOPICAL CREAM [Jungshea UNSEEN SUNSCREEN]


name: GLYCERIN 12.5 mg in 50 mL / TITANIUM DIOXIDE 12.5 mg in 50 mL / TOCOPHEROL 10 mg in 50 mL CUTANEOUS CREAM


name: OCTISALATE 4.7 g in 100 g / ZINC OXIDE 15 g in 100 g TOPICAL LIPSTICK [TATCHA THE KISSU LIP TINT SPF 25 PLUM BLOSSOM]


name: ZINC OXIDE 21 g in 100 g TOPICAL CREAM [Hydrating Mineral Sunscreen BS SPF30]


name: ASIAN GINSENG 15 mg in 100 mL / PURSLANE 15 mg in 100 mL / COCONUT OIL 25 mg in 100 mL / LAVENDER OIL 15 mg in 100 mL / GINGER 15 mg in 100 mL CUTANEOUS CREAM


name: AVOCADO OIL 15 g in 100 g / SALICYLIC ACID 20 g in 100 g / TURMERIC 25 g in 100 g / JOJOBA OIL 25 g in 100 g CUTANEOUS PASTE


name: CASTOR OIL 18 mg in 60 mg / ACETYL TETRAPEPTIDE-3 9 mg in 60 mg / TEA TREE OIL 15 mg in 60 mg / ARABICA COFFEE OIL 12 mg in 60 mg CUTANEOUS LIQUID


name: COCONUT OIL 12 mg in 60 mL / MARINE COLLAGEN, SOLUBLE 15 mg in 60 mL / GLYCERIN 12 mg in 60 mL / ROSEMARY 6 mg in 60 mL CUTANEOUS CREAM


name: COCONUT OIL 20 mg in 100 mL / OLIVE OIL 10 mg in 100 mL / ARGAN OIL 30 mg in 100 mL / AVOCADO OIL 30 mg in 100 mL CUTANEOUS OIL


name: GLYCERIN 15 mg in 100 g / MARINE COLLAGEN, SOLUBLE 15 mg in 100 g / OLIVE OIL 15 mg in 100 g / LEPIDIUM MEYENII ROOT 15 mg in 100 g / SUNFLOWER OIL 15 mg in 100 g CUTANEOUS CREAM


name: GLYCERIN 15 mg in 60 g / GENTIANA SCABRA ROOT 6 mg in 60 g / SUNFLOWER OIL 12 mg in 60 g / CALENDULA OFFICINALIS FLOWER 12 mg in 60 g CUTANEOUS CREAM


name: LEPIDIUM SATIVUM WHOLE 15 mg in 100 g / HYDROLYZED WHEAT PROTEIN (ENZYMATIC, 3000 MW) 25 mg in 100 g / SHEANUT OIL 20 mg in 100 g / HAIR KERATIN AMINO ACIDS 20 mg in 100 g CUTANEOUS CREAM


name: MYRTUS COMMUNIS LEAF 10 mg in 50 mL / EDETATE DISODIUM 5 mg in 50 mL / RETINOL 10 mg in 50 mL / HYALURONATE SODIUM 10 mg in 50 mL / ASCORBIC ACID 5 mg in 50 mL CUTANEOUS CREAM


name: NIACINAMIDE 18 mg in 120 mL / HYALURONIC ACID 18 mg in 120 mL / ASIAN GINSENG 18 mg in 120 mL CUTANEOUS LIQUID


name: OLIVE OIL 25 mg in 100 mL / MENTHA PIPERITA LEAF 30 mg in 100 mL / DIMETHICONE 8 mg in 100 mL / ROSEMARY 30 mg in 100 mL CUTANEOUS CREAM


name: ROSEMARY OIL 15 mg in 100 g / ALMOND OIL 15 mg in 100 g / MACADAMIA OIL 15 mg in 100 g / SUNFLOWER OIL 15 mg in 100 g / PEPPERMINT OIL 15 mg in 100 g CUTANEOUS CREAM


name: OCTINOXATE 7.5 g in 100 g / OXYBENZONE 4 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL STICK [The Nethercutt Collection Hemp Vanilla SPF 30 Broad Spectrum Sunscreen Lip Balm SPF 30]


name: OCTINOXATE 7.5 g in 36 mL / TITANIUM DIOXIDE 5 g in 36 mL TOPICAL CREAM [JENTRY KELLEY TINTED PRIMER BROAD SPECTRUM SPF 20- LIGHT]


name: ZINC OXIDE 22 g in 100 g TOPICAL STICK [KINeSYS Pro Sport Clear Mineral Sunscreen Stick Broad Spectrum SPF45]


name: ZINC OXIDE 90 mg in 1 g / CERAMIDE 1 5 mg in 1 g / HOMOSALATE 100 mg in 1 g / NIACINAMIDE 40 mg in 1 g / CERAMIDE 3 5 mg in 1 g / CERAMIDE 6 II 5 mg in 1 g / OCTOCRYLENE 20 mg in 1 g / TITANIUM DIOXIDE 50 mg in 1 g TOPICAL CREAM [Face50PremiumSunscreenFaceLotionBroadSpectrum]


name: CNIDIUM MONNIERI FRUIT 6 mg in 20 g / ALOE VERA LEAF 2 mg in 20 g / SOPHORA FLAVESCENS ROOT 4 mg in 20 g / PHELLODENDRON AMURENSE BARK 2 mg in 20 g TOPICAL CREAM


name: COCONUT 25 mg in 100 mL / TOCOPHEROL 20 mg in 100 mL DENTAL LIQUID


name: CYANOCOBALAMIN 17.96 mg in 89.8 g / TOCOPHEROL 26.94 mg in 89.8 g / GINGER 8.98 mg in 89.8 g / MENTHA ARVENSIS WHOLE 8.98 mg in 89.8 g CUTANEOUS LIQUID


name: GLUCAN ENDO-1,3-.ALPHA.-GLUCOSIDASE AGN1 2.25 mg in 15 mg / APIS MELLIFERA VENOM 1.5 mg in 15 mg / HYALURONIC ACID 3 mg in 15 mg / NIACINAMIDE 4.5 mg in 15 mg / GLYCERIN 2.25 mg in 15 mg CUTANEOUS LIQUID


name: HYALURONIC ACID 7.5 g in 50 g / ASCORBIC ACID 10 g in 50 g / ARBUTIN 7.5 g in 50 g / GLYCERIN 5 g in 50 g / RETINOL 15 g in 50 g CUTANEOUS CREAM


name: JOJOBA OIL 15 mg in 100 mL / OLIVE OIL 21 mg in 100 mL CUTANEOUS CREAM


name: LANOLIN 5 mg in 100 g / AVOCADO OIL 25 mg in 100 g / FRAGARIA VESCA FRUIT 20 mg in 100 g / OLIVE OIL 25 mg in 100 g TOPICAL CREAM


name: LICORICE 1.8 mg in 10 mg CUTANEOUS PATCH


name: LICORICE 30 mg in 120 g / MELALEUCA ALTERNIFOLIA LEAF 30 mg in 120 g TOPICAL CREAM


name: LINSEED OIL 15 mg in 60 mL / THUJA OCCIDENTALIS LEAF 12 mg in 60 mL / ROSEMARY OIL 9 mg in 60 mL CUTANEOUS LIQUID


name: ALLANTOIN 3 mg in 20 mL / GLYCERIN 3 mg in 20 mL CUTANEOUS LIQUID


name: ALOE VERA LEAF 15 mg in 50 g / JOJOBA OIL 5 mg in 50 g / SHEANUT OIL 10 mg in 50 g / HYALURONIC ACID 5 mg in 50 g CUTANEOUS CREAM


name: BENZOCAINE 5 g in 100 mL ORAL SPRAY [Xesso Neo]


name: PALM OIL 119.88 mg in 120 g CUTANEOUS CREAM


name: PALM OIL 99.89 mg in 100 g CUTANEOUS OIL


name: PANTHENOL 6 mg in 30 mL / HYALURONIC ACID 6 mg in 30 mL TOPICAL CREAM


name: ROSEMARY OIL 10.5 mg in 35 mL / GINGER 7 mg in 35 mL / CASTOR OIL 3.5 mg in 35 mL / ASIAN GINSENG 3.5 mg in 35 mL TOPICAL OIL


name: SESAME SEED 25 mg in 100 mL / ASIAN GINSENG 25 mg in 100 mL / GINGER 20 mg in 100 mL CUTANEOUS LIQUID


name: SODIUM BICARBONATE 2 mg in 10 mL / CALCIUM CHLORIDE 2.5 mg in 10 mL / MAGNESIUM CHLORIDE 2 mg in 10 mL / N-ACETYLGLUCOSAMINE 1 mg in 10 mL OPHTHALMIC LIQUID


name: SOPHORA FLAVESCENS ROOT 4 mg in 20 g / ALOE VERA LEAF 4 mg in 20 g / GINKGO 2 mg in 20 g / PHELLODENDRON AMURENSE BARK 5 mg in 20 g CUTANEOUS CREAM


name: VIOLA ODORATA WHOLE 6 mg in 20 g / CNIDIUM MONNIERI FRUIT 2 mg in 20 g / SOPHORA FLAVESCENS WHOLE 2 mg in 20 g / FU LING 4 mg in 20 g CUTANEOUS CREAM


name: ZINC OXIDE 18 g in 100 g TOPICAL STICK [KINeSYS Pro Sport Lip Balm with Shea Butter Broad Spectrum 30]


name: ZINC OXIDE 20 g in 100 mL TOPICAL LOTION [Rio Radiance SPF 50 BodyLotion]


name: CERAMIDE 1 5 mg in 1 g / OCTOCRYLENE 20 mg in 1 g / NIACINAMIDE 40 mg in 1 g / CERAMIDE 6 II 5 mg in 1 g / HOMOSALATE 100 mg in 1 g / TITANIUM DIOXIDE 50 mg in 1 g / ZINC OXIDE 90 mg in 1 g / CERAMIDE 3 5 mg in 1 g TOPICAL CELLULAR SHEET [sunscreenlotionforface]


name: AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / HOMOSALATE 68 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [ZO Skin Health Smart Tone Broad-Spectrum Sunscreen SPF 50]


name: CENTELLA ASIATICA TRITERPENOIDS 29.4 mg in 60 mL / MARINE COLLAGEN, SOLUBLE 9 mg in 60 mL / TITANIUM DIOXIDE 6 mg in 60 mL / HYALURONIC ACID 3.6 mg in 60 mL CUTANEOUS CREAM


name: HOMOSALATE 1.89 g in 21 g / OCTOCRYLENE 1.89 g in 21 g / OCTISALATE 0.94 g in 21 g / AVOBENZONE 0.6 g in 21 g TOPICAL STICK [CALIFORNIA ALOE FRESH POW DERY SUN]


name: OCTISALATE 7 g in 100 g / OCTOCRYLENE 9 g in 100 g TOPICAL LIPSTICK


name: TITANIUM DIOXIDE 4.5 g in 100 g / ZINC OXIDE 4 g in 100 g TOPICAL SPRAY [SPF30 Sunscreen Cariposa]


name: TITANIUM DIOXIDE 4.5 g in 100 mL / ZINC OXIDE 4 g in 100 mL TOPICAL CREAM [SPF 30 Mineral Sunscreen Cariposa]


name: ZINC OXIDE 10 mg in 50 g / HYALURONIC ACID 12.5 mg in 50 g / TOCOPHEROL 2.5 mg in 50 g / TITANIUM DIOXIDE 10 mg in 50 g CUTANEOUS CREAM


name: ZINC OXIDE 3 g in 30 mL / TITANIUM DIOXIDE 6 g in 30 mL TOPICAL CREAM [MINERAL LP FOUNDATION COTTON]


name: ACETYL TETRAPEPTIDE-3 18 mg in 60 mL / CASTOR OIL 6 mg in 60 mL / ARABICA COFFEE OIL 12 mg in 60 mL / TEA TREE OIL 6 mg in 60 mL TOPICAL LIQUID


name: ALOE VERA LEAF 27.6 g in 184 g / LACTOBIONIC ACID 38.64 g in 184 g ORAL SUSPENSION


name: APIS MELLIFERA VENOM 1.6 mg in 8 g / GINGER 1.6 mg in 8 g / PROPOLIS WAX 1.6 mg in 8 g / SAGE 0.8 mg in 8 g TOPICAL BEAD


name: ARBUTIN 2.1 mg in 30 mL / SHEANUT OIL 9 mg in 30 mL / SQUALENE 6 ng in 30 mL / TOCOPHEROL 3.9 mg in 30 mL CUTANEOUS CREAM


name: ARNICA MONTANA FLOWER 1.85 mg in 18.5 g / APIS MELLIFERA VENOM 5.55 mg in 18.5 g / ARTEMISIA VULGARIS ROOT 3.7 mg in 18.5 g / SAFFLOWER 3.7 mg in 18.5 g CUTANEOUS PATCH


name: ARTEMISIA VULGARIS ROOT 1.37 mg in 13.67 g / CINNAMOMUM CAMPHORA WHOLE 2.73 mg in 13.67 g / MENTHA PIPERITA LEAF 2.73 mg in 13.67 g / ARABICA COFFEE BEAN 2.73 mg in 13.67 g TOPICAL PATCH


name: ARTEMISIA VULGARIS ROOT 2.33 mg in 9.3 g / GLYCYRRHIZA GLABRA 2.33 mg in 9.3 g / GINGER 1.86 mg in 9.3 g / ASIAN GINSENG 0.93 mg in 9.3 g TOPICAL PATCH


name: ASCORBIC ACID 10 mg in 100 mg / AVOCADO OIL 20 mg in 100 mg / JOJOBA OIL 15 mg in 100 mg / TURMERIC 25 mg in 100 mg CUTANEOUS CREAM


name: ASIAN GINSENG 20 g in 100 g / PROPOLIS WAX 15 g in 100 g DENTAL CREAM


name: COLLAGEN, SOLUBLE, FISH SKIN 4 mg in 4 mg CUTANEOUS PATCH


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [Anyi Beauty Peptides Face Lift Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [Anyi Beauty Peptides Smoothes Wrinkles Face Cream]


name: GINGER 1 mg in 10 mg / ARTEMISIA ARGYI LEAF 1.5 mg in 10 mg / ASCORBIC ACID 1 mg in 10 mg / BAMBUSA VULGARIS TOP 1.5 mg in 10 mg / CAMPANULA ROTUNDIFOLIA WHOLE 3 mg in 10 mg / BAMBUSA ARUNDINACEA STEM 2 mg in 10 mg CUTANEOUS PATCH


name: GLYCERIN 12.5 g in 50 g / ARABICA COFFEE BEAN 7.5 g in 50 g / RETINOL 10 g in 50 g / HYALURONIC ACID 12.5 g in 50 g CUTANEOUS CREAM


name: GLYCERIN 3.6 mg in 12 mg CUTANEOUS PATCH


name: GLYCYRRHIZA GLABRA LEAF 12 mg in 60 mL / GINKGO 12 mg in 60 mL / PROPOLIS WAX 12 mg in 60 mL / MENTHA PIPERITA LEAF 6 mg in 60 mL AURICULAR (OTIC) SPRAY


name: HYALURONATE SODIUM 4.5 mg in 50 mL / NIACINAMIDE 7.5 mg in 50 mL / PANTHENOL 10.5 mg in 50 mL CUTANEOUS CREAM


name: LONICERA JAPONICA FLOWER 5 mg in 20 g / ALOE VERA LEAF 4 mg in 20 g / TURMERIC 2 mg in 20 g / MENTHA X PIPERITA WHOLE 4 mg in 20 g TOPICAL CREAM


name: MAGNOLIA OBOVATA BARK 2 mg in 20 mL / LONICERA JAPONICA FLOWER 4 mg in 20 mL / LITHOSPERMUM ERYTHRORHIZON ROOT 5 mg in 20 mL / BUPLEURUM FALCATUM ROOT 4 mg in 20 mL NASAL SPRAY


name: MENTHA ARVENSIS WHOLE 1.75 mg in 7 g / OLIVE OIL 0.7 mg in 7 g / COMFREY LEAF 1.4 mg in 7 g / SQUALANE 1.4 mg in 7 g TOPICAL OINTMENT


name: MORUS ALBA BARK 1.793 g in 100 g / SODIUM BENZOATE 0.0815 g in 100 g / SESAMUM INDICUM WHOLE 1.793 g in 100 g / ALCOHOL 20 g in 100 g / UNDARIA PINNATIFIDA 2.608 g in 100 g / CAMELLIA SINENSIS WHOLE 2.608 g in 100 g / PINUS DENSIFLORA LEAF 1.793 g in 100 g / ARTEMISIA VULGARIS WHOLE 1.793 g in 100 g TOPICAL SPRAY [BEVERHILL HAIR TONIC]


name: NIACINAMIDE 1.8 g in 45 mL / ADENOSINE 0.018 g in 45 mL TOPICAL LIQUID [ANYI BEAUTY PEPTIDES FACIAL SERUM]


name: NIACINAMIDE 1.8 g in 45 mL / ADENOSINE 0.018 g in 45 mL TOPICAL LIQUID [ANYI BEAUTY Vitamin C Evens Skin Tone Face Serum]


name: NIACINAMIDE 1.8 g in 45 mL / ADENOSINE 0.018 g in 45 mL TOPICAL LIQUID [NOWNOON 2% BHA Liquid Facial Serum]


name: NIACINAMIDE 12.5 mg in 50 mL / HYALURONATE SODIUM 7.5 mg in 50 mL CUTANEOUS CREAM


name: NIACINAMIDE 4.5 g in 30 g / ASCORBIC ACID 4.5 g in 30 g / COLLAGEN, SOLUBLE, FISH SKIN 3 g in 30 g / HYALURONIC ACID 3 g in 30 g / RETINOL 6 g in 30 g CUTANEOUS LOTION


name: OLIVE OIL 20 mg in 100 mL / CASTOR OIL 20 mg in 100 mL / ALMOND OIL 10 mg in 100 mL / JOJOBA OIL 20 mg in 100 mL TOPICAL LIQUID


name: PEA FIBER 5 g in 100 g / LACTIC ACID 10 g in 100 g / COTTON FIBER 5 g in 100 g TOPICAL POWDER [Hankki ssog Pre-Biome Shake (Detox and Diet Shake)]


name: PEA FIBER 5 g in 100 g / LACTIC ACID 10 g in 100 g / COTTON FIBER 5 g in 100 g TOPICAL POWDER [Hankki ssog Pre-Biome Shake (Detox and Diet, Body Change)]


name: PHELLODENDRON AMURENSE BARK 6 mg in 30 mL / CNIDIUM MONNIERI FRUIT 6 mg in 30 mL / SOPHORA FLAVESCENS WHOLE 9 mg in 30 mL / LONICERA JAPONICA FLOWER 6 mg in 30 mL CUTANEOUS SPRAY


name: PLATYCLADUS ORIENTALIS WHOLE 1.6 mg in 8 mg CUTANEOUS PATCH


name: RICE BRAN 1.75 mg in 7 mg / NIACINAMIDE 1.4 mg in 7 mg / XYLITOL 1.05 mg in 7 mg / SEPIA ESCULENTA BONE 0.7 mg in 7 mg DENTAL GEL


name: ROSEMARY OIL 2 mg in 10 mL / PEPPERMINT OIL 2.5 mg in 10 mL / GLYCERIN 1 mg in 10 mL / LAVENDER OIL 2 mg in 10 mL CUTANEOUS STICK


name: SOYBEAN 5 mg in 50 mg / PUMPKIN 7.5 mg in 50 mg / BIFIDOBACTERIUM ANIMALIS LACTIS 10 mg in 50 mg / BACILLUS PUMILUS 7.5 mg in 50 mg / WHITE RICE 5 mg in 50 mg CUTANEOUS CREAM


name: SQUALANE 20 mg in 100 mL / ARGAN OIL 20 mg in 100 mL / OLIVE OIL 20 mg in 100 mL / ROSEMARY OIL 10 mg in 100 mL TOPICAL OIL


name: TOCOPHEROL 3 mg in 30 g / BLACK OLIVE 6 mg in 30 g / SUNFLOWER OIL 6 mg in 30 g / ALOE 7.5 mg in 30 g CUTANEOUS CREAM


name: WINE GRAPE 7.5 mg in 30 mL / ASCORBIC ACID 7.5 mg in 30 mL / RETINOL 6 mg in 30 mL / GLYCERIN 4.5 mg in 30 mL CUTANEOUS LIQUID


name: ZINC OXIDE 20 g in 100 mL TOPICAL LOTION [SPF33 Mineral Facial Cariposa]


name: HOMOSALATE 70 mg in 1 mL / OCTISALATE 50 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [SUN CONTROL BROAD SPECTRUM SPF 30]


name: TITANIUM DIOXIDE 12 g in 48 g / SQUALANE 7.2 g in 48 g / GLYCERIN 9.6 g in 48 g / TOCOPHEROL 4.8 g in 48 g CUTANEOUS CREAM


name: ZINC OXIDE 241 mg in 1 g TOPICAL POWDER [Topix Mineral Finishing Sunscreen SPF 30]


name: ASIAN GINSENG 6 mg in 30 g / GINGER 6 mg in 30 g / SALVIA ROSMARINUS FLOWER 6 mg in 30 g / REYNOUTRIA MULTIFLORA ROOT 6 mg in 30 g TOPICAL CREAM


name: CASTOR OIL 100 g in 100 mL TOPICAL OIL [ANYI BEAUTY CASTOR Oil]


name: CASTOR OIL 100 g in 100 mL TOPICAL OIL [ROSEMARY MINT STRENGTHENING Oil]


name: LAVENDER OIL 6 mg in 30 mL / JOJOBA OIL 6 mg in 30 mL / ROSEMARY OIL 3 mg in 30 mL / CASTOR OIL 6 mg in 30 mL TOPICAL OIL


name: ZINC OXIDE 17.5 g in 100 g TOPICAL STICK [Brush On Block Quick Stick SPF 40 Mineral Stick]


name: HYALURONIC ACID 20 mg in 100 mL / TITANIUM DIOXIDE 25 mg in 100 mL / PROPYLENE GLYCOL 20 mg in 100 mL / TOCOPHEROL 10 mg in 100 mL CUTANEOUS LOTION


name: TOCOPHEROL 10 mg in 50 g / TITANIUM DIOXIDE 10 mg in 50 g / HYALURONIC ACID 10 mg in 50 g / ASCORBIC ACID 10 mg in 50 g CUTANEOUS GEL


name: ZINC OXIDE 3 g in 30 mL / TITANIUM DIOXIDE 6 g in 30 mL TOPICAL CREAM [MINERAL LP FOUNDATION Bisque]


name: GINGER 16.5 mg in 66 g / ARTEMISIA VULGARIS ROOT 16.5 mg in 66 g / BLACK PEPPER 16.5 mg in 66 g CUTANEOUS PATCH


name: GLYCERIN 6 mg in 30 g / CURCUMIN 6 mg in 30 g / GLUCOSAMINE SULFATE 6 mg in 30 g CUTANEOUS CREAM


name: HYALURONIC ACID 2.5 mg in 10 mg / RETINOL 0.3 mg in 10 mg / ALOESIN 2.2 mg in 10 mg CUTANEOUS LIQUID


name: JOJOBA OIL 20 mg in 100 mL / AVOCADO OIL 20 mg in 100 mL / OLIVE OIL 20 mg in 100 mL / GLYCERIN 20 mg in 100 mL TOPICAL OIL


name: LAVENDER OIL 6 mg in 30 mL / SOPHORA FLAVESCENS WHOLE 6 mg in 30 mL / VERBASCUM THAPSUS WHOLE 6 mg in 30 mL / GINKGO 6 mg in 30 mL AURICULAR (OTIC) SPRAY


name: OLIVE OIL 15 mg in 100 mL / GRAPE SEED OIL 15 mg in 100 mL / SESAME OIL 15 mg in 100 mL / PALM OIL 15 mg in 100 mL / COCONUT OIL 15 mg in 100 mL TOPICAL OIL


name: RASPBERRY 6 mg in 30 mg / ALOE VERA LEAF 3 mg in 30 mg / FUCOXANTHIN 4.5 mg in 30 mg / GINGER OIL 3 mg in 30 mg / GLUTATHIONE 4.5 mg in 30 mg CUTANEOUS OIL


name: RETINOL 10 g in 50 g / HYALURONIC ACID 7.5 g in 50 g / GELATIN HYDROLYSATE (PORCINE SKIN, MW 3000) 12.5 g in 50 g / ASCORBIC ACID 5 g in 50 g CUTANEOUS CREAM


name: ALOE VERA LEAF 7.5 mg in 30 mL / OLIVE OIL 6 mg in 30 mL / TOCOPHEROL 3 mg in 30 mL / ALMOND OIL 6 mg in 30 mL TOPICAL OIL


name: APIS MELLIFERA VENOM 12.2 mg in 61 g / GINGER 12.2 mg in 61 g / SAGE 12.2 mg in 61 g / ANGELICA ARCHANGELICA ROOT 12.2 mg in 61 g CUTANEOUS BEAD


name: CALENDULA OFFICINALIS FLOWER 11.8 mg in 59 g / GINGER 11.8 mg in 59 g / APIS MELLIFERA VENOM 11.8 mg in 59 g / ARTEMISIA VULGARIS ROOT 11.8 mg in 59 g CUTANEOUS BEAD


name: SQUALANE 1.5 mg in 10 mg / ASCORBIC ACID 2.5 mg in 10 mg / SILYBUM MARIANUM SEED 2 mg in 10 mg / GLYCERIN 1.5 mg in 10 mg CUTANEOUS LIQUID


name: TOCOPHEROL 2 mg in 10 g / CENTELLA ASIATICA TRITERPENOIDS 2 mg in 10 g / REHMANNIA GLUTINOSA WHOLE 2 mg in 10 g / HYALURONIC ACID 2 mg in 10 g CUTANEOUS PATCH


name: GLYCERIN 6 mg in 30 mL / CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE 6 mg in 30 mL / ALLANTOIN 6 mg in 30 mL / HAMAMELIS VIRGINIANA LEAF 6 mg in 30 mL CUTANEOUS LIQUID


name: HYALURONATE SODIUM 3.75 g in 25 g / TOCOPHEROL 6.25 g in 25 g / GLYCERIN 6.25 g in 25 g CUTANEOUS LIQUID


name: HYALURONIC ACID 0.7 g in 7 g / SQUALANE 1.4 g in 7 g / TOCOPHEROL 1.05 g in 7 g / GLYCERIN 1.75 g in 7 g CUTANEOUS STICK


name: MILK THISTLE 1.05 mg in 7 mg / WHITE PEPPER 1.05 mg in 7 mg / GINGER 1.05 mg in 7 mg / APIS MELLIFERA VENOM 2.8 mg in 7 mg CUTANEOUS PATCH


name: NICOTINAMIDE MONONUCLEOTIDE 13.5 mg in 90 g / CARRAGEENAN 13.5 mg in 90 g / PALMITOYL TRIPEPTIDE-1 13.5 mg in 90 g / SHEA BUTTER 13.5 mg in 90 g / NELUMBO NUCIFERA FLOWER 13.5 mg in 90 g CUTANEOUS SOAP


name: SESAME SEED 5 mg in 30 g / SAFFLOWER 5 mg in 30 g / GENTIANA LUTEA ROOT 5 mg in 30 g / ASCORBIC ACID 5 mg in 30 g / GERANIUM MACULATUM ROOT 5 mg in 30 g CUTANEOUS CREAM


name: TITANIUM DIOXIDE 96.075 mg in 1 g TOPICAL CREAM [Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Alabaster]


name: HAMAMELIS VIRGINIANA LEAF 0.1 g in 100 mL TOPICAL LIQUID [Deodorant sprays]


name: OCTISALATE 0.21 g in 4.25 g / OCTOCRYLENE 0.06 g in 4.25 g / OCTINOXATE 0.28 g in 4.25 g / AVOBENZONE 0.09 g in 4.25 g TOPICAL STICK [Broad Spectrum SPF 15 Sunscreen Fresh Berry Lip Balm]


name: CERAMIDE 6 II 5 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 20 mg in 1 g / NIACINAMIDE 40 mg in 1 g / ZINC OXIDE 90 mg in 1 g / CERAMIDE 3 5 mg in 1 g / CERAMIDE 1 5 mg in 1 g / TITANIUM DIOXIDE 50 mg in 1 g TOPICAL CREAM [ADVANCEDSUNSAFETYSOLUTION]


name: TOCOPHEROL 3 mg in 30 mL / GLYCERIN 7.5 mg in 30 mL / ZINC OXIDE 6 mg in 30 mL / SALICYLIC ACID 6 mg in 30 mL CUTANEOUS LOTION


name: COCAMIDOPROPYL BETAINE 6 g in 100 mL TOPICAL LIQUID [Antibacterial lotions]


name: NIACINAMIDE 4.5 g in 15 g CUTANEOUS STICK


name: PUMPKIN SEED OIL 58.99 mg in 60 mL CUTANEOUS OIL


name: RETINOL 3.75 mg in 50 mL / HYDROLYSED MARINE COLLAGEN (ENZYMATIC; 2000 MW) 7.5 mg in 50 mL / TOCOPHEROL 3.75 mg in 50 mL / HYALURONIC ACID 3.75 mg in 50 mL CUTANEOUS CREAM


name: ALOE VERA LEAF 25 mg in 100 mg / GLYCERIN 20 mg in 100 mg / CHAMOMILE 15 mg in 100 mg / OLIVE OIL 10 mg in 100 mg CUTANEOUS LIQUID


name: ARABICA COFFEE BEAN 5 mg in 25 g / ORANGE PEEL 5 mg in 25 g / SCUTELLARIA BAICALENSIS ROOT 5 mg in 25 g / ANGELICA SINENSIS ROOT 5 mg in 25 g CUTANEOUS PATCH


name: {168 (danicopan 100 MG Oral Tablet [Voydeya]) } Pack [Voydeya 200 MG Dose Card]


name: emollient combination no.121 TOPICAL CREAM (GRAM)


name: emollient combination no.121 TOPICAL LOTION (GRAM)


name: gel-matrix pad,silicone-dimethicone-dime-decameoct-oct-vit E 3" X 5.5" TOPICAL KIT


name: {2 (sotatercept-csrk 45 MG Injection) } Pack


name: {2 (sotatercept-csrk 60 MG Injection) } Pack


name: {84 (danicopan 100 MG Oral Tablet) / 84 (danicopan 50 MG Oral Tablet) } Pack


name: {168 (danicopan 100 MG Oral Tablet) } Pack


name: {180 (danicopan 100 MG Oral Tablet) } Pack


name: {90 (danicopan 100 MG Oral Tablet) / 90 (danicopan 50 MG Oral Tablet) } Pack


name: VAD DRIVELINE MAINTENANCE KIT CM#DT17415


name: CATHETER FOLEY SILICONE 2-WAY18FR 10ML M#DYND141018


name: CATHETER,INTERMITTENT COUDE 10FR CURE #ULTRAM10C


name: TRACHEOSTOMY CARE KIT MEDLINE #DYND40580


name: DRESSING,ADAPTIC TOUCH NON-ADHERING SILICONE 5IN X 6IN


name: COMPLEAT ORGANIC BLENDS PLANT BASED LIQUID


name: Screen for contraindications (e.g., decreased platelets, decreased skin integrity, deep vein thrombosis, areas with open lesions, redness or inflammation, tumors, hypersensitivity to touch)


name: Place in supine position in relaxed manner


name: Explain procedure and benefits of abdominal massage


name: Instruct on diaphragmatic breathing technique


name: Maintain privacy before exposing abdomen


name: Move hands in clockwise or counterclockwise motions, or form the letters I, L, U, and O with hand motions


name: Perform abdominal massage at least 2 hours after having meal


name: Instruct on appropriate volume of daily fluid intake if there is no fluid limitation


name: Use essential oils during massage to enhance reduced symptoms (e.g., peppermint, fennel, ginger, anise, cinnamon)


name: Instruct to defecate by sitting in position with hip bent in 90-degree angle while body upright, if possible


name: Instruct person on complete bed rest to defecate in lateral position with hip and knee flexed


name: Monitor bowel habits and any distention after abdominal massage daily


name: Identify individuals who are at risk for possible abuse (e.g., pregnancy complications, low birth weight, disability, history associated with abuse or neglect, rejection, excessive criticism, feelings of being worthless and unloved, dependency upon another for cares)


name: Consider parental risk factors for possible abuse (e.g., substance abuse, criminal behavior, family conflict or violence, mental health issues, child being perceived as problem by parents, unplanned pregnancy, youth pregnancy, single or unmarried parents, parental temperament, use of physical punishment)


name: Identify social and environmental factors that may be indicators for possible abuse (e.g., social isolation, low self-esteem, physical health conditions, housing stress, socioeconomic stressors, parental unemployment, lack of prenatal care, low social support, neighborhood violence, community disadvantage)


name: Identify persons who have difficulty trusting others or feel disliked by others


name: Identify if person feels asking for help is indicator of personal incompetence


name: Identify whether adult at risk has close friends or family available to help with dependents


name: Determine relationship between caregivers and individuals


name: Determine whether adults can take over for each other when needed to deal with dependent family member


name: Determine whether child or dependent adult is viewed differently by adult based on sex, appearance, or behavior


name: Identify crisis situations that may trigger abuse (e.g., poverty, unemployment, divorce, loss)


name: Observe ill or injured child or dependent adult for signs of abuse


name: Encourage admission of child or dependent adult for further observation and investigation, as appropriate


name: Monitor for underreactions or overreactions on part of adult


name: Monitor child or dependent adult for extreme compliance, such as passive submission to hospital procedures


name: Monitor parent who holds newborn at arm's length, handles newborn awkwardly, or asks for excessive assistance


name: Monitor for repeated visits to clinic, emergency room, or health care provider office for minor problems


name: Monitor for progressive deterioration in physical and emotional care provided to child or dependent adult in family


name: Establish rapport with families with history of abuse for longterm evaluation and support


name: Refer person at risk to appropriate specialists


name: Inform appropriate health care provider of observations indicative of abuse


name: Report any situations in which abuse suspected to proper authorities


name: Refer person to shelters for abused spouses, as appropriate


name: Refer parents to support group support, as appropriate


name: Encourage person to contact police when physical safety threatened


name: Inform person of laws and services relevant to abuse


name: Identify patterns of behavior, thinking, and feeling in which person experiences "control over" their religious journey by another


name: Report suspected abuse to proper church and legal authorities


name: Determine whether individual has religious functional network to assist in meeting needs for belonging, care, and transcendence in healthy manner


name: Offer prayer and healing services for person and healing of family or congregation, if comfortable doing so and if individual chooses


name: Provide interpersonal support on regular basis, as needed


name: Refer for appropriate religious counseling focusing on needs of individual


name: Provide resources to victimized individual on benefits of forgiveness, when and if appropriate


name: Refer to professional specialist if occult or satanic ritual abuse suspected


name: Document interactions per organizational policy


name: Calculate urine chloride concentration to assist in determining causes of metabolic alkalosis (e.g., saline responsive is indicated when urine chloride concentration is less than 15 mmol/L; non-saline responsive is indicated when urine chloride concentration is greater than 25 mmol/L)


name: Use open-ended questions or statements to encourage expression of thoughts, feelings, and concerns


name: Refrain from making any judgments about person and their experience (e.g., prejudice, bias, assumptions)


name: Focus on interaction by suppressing personal concerns and other distractions


name: Display awareness of and sensitivity to emotions


name: Mirror and reflect on information and emotions by periodically paraphrasing key points


name: Time response so that it reflects understanding of received message


name: Clarify message through use of probing questions and feedback


name: Use series of interactions to discover meaning of behavior


name: Arrange for any mutual responsibilities and follow-up, if needed


name: Introduce self and role in providing care


name: Identify using at least two identifiers (e.g., name, birth date)


name: Determine if has sensory or communication need (e.g., glasses, hearing aid, need for an interpreter) or preferred communication method


name: Provide professional translator or telephone interpreter services if does not speak, read, or understand English


name: Determine educational background, health literacy level, and ability to understand instructions


name: Provide with advance care directive information (e.g., living will, durable power of attorney for health care)


name: Obtain copies of advance care directives, if available


name: Orient to expectations of care, including relevant healthcare agency policies and procedures


name: Orient to immediate environment, including call lights, bathroom facilities, and equipment


name: Review health history including past medical illnesses, medications, and allergies


name: Review physical, financial, psychosocial, and religious assessments, as appropriate


name: Determine cultural variables that require accommodation or adaptation (e.g., dietary preferences, clothing requirements, beliefs about healing and wellness)


name: Review medications including herbal or OTC medications


name: Review risk status (e.g., risk for falls, tuberculosis screening, skin assessment)


name: Determine if uses any assistive devices and provide, after assuring devices safe to use


name: Perform preliminary testing and screening per agency policies and person condition


name: Note verbal and nonverbal behaviors and responses


name: Determine perception of illness, health care needs, knowledge of health problems and expectations of care


name: Identify persons at high risk for readmission based on condition, previous hospitalizations, emergency department visits, and social determinants of health (e.g., LACE criteria [Length of stay during index admission, Acute [emergent admissions], Charlson comorbidity index, ED visits])


name: Initiate ongoing flexible plan for discharge at admission (e.g., regular evaluation of discharge readiness, periodic discussions related to discharge plans)


name: Determine home resources including family or caregiver availability, as early as possible


name: Encourage early involvement in all interactions related to home care and discharge needs


name: Implement safety precautions, as appropriate (e.g., fall protocol, isolation precautions)


name: Label clinical record, room door, and head of bed with safety alerts, including wrist band identification, as indicated


name: Notify health care provider of admission and status


name: Obtain health care provider orders for care


name: Build trusting relationship with adolescent


name: Encourage adolescent to be actively involved in decisions regarding own health care


name: Discuss developmental milestones and associated behaviors with adolescent and parent


name: Screen for health problems relevant to adolescent and suggested by history (e.g., anemia; hypertension; hearing and vision disorders; hyperlipidemia; oral health problems; abnormal sexual maturation; abnormal physical growth; body image disturbances; eating disorders; poor nutrition; alcohol, tobacco, or drug use; unhealthy sexual behavior; infectious disease; poor self-concept; low self-esteem; depression; difficult relationships; abuse; learning problems; work problems)


name: Encourage yearly physical and vision screening


name: Instruct on self-breast or self-testicle exam, as indicated


name: Encourage to practice good dental hygiene


name: Provide education and encourage age-appropriate immunizations


name: Provide health counseling and guidance to adolescent and parent, as needed


name: Acknowledge pubertal development stage and provide education on developmental process


name: Promote independence with ADLs, as appropriate


name: Encourage participation in safe exercise on regular basis


name: Encourage responsible sexual behavior and screen for STDs


name: Enhance communication and assertiveness skills


name: Facilitate sense of responsibility for self and others


name: Evaluate teen for stressors and stress management techniques


name: Evaluate mood and provide resources for concerns (e.g., depression, suicidal ideation) as needed


name: Discuss body modification, such as tattoos and piercings


name: Determine readiness to receive information


name: Facilitate discussions about preferences regarding future health care


name: Facilitate decision-making and informed choices based on preferences


name: Encourage expression of feelings and emotions during discussions


name: Identify hopes, fears, and personal life goals and values related to future health care


name: Discuss treatment, risks and benefits, and symptom management


name: Respect right to receive or not receive information about health and prognosis


name: Assist to identify surrogate decision maker when unable to make own decisions


name: Facilitate decision-making hierarchy with durable power of attorney for health care


name: Include other health care professionals in discussions including spiritual and religious support


name: Assist in filing legally recognized advanced directives if appropriate


name: Revisit discussion and update over time as health condition changes


name: Document discussions, preferences, and decisions


name: Limit insertion of ETs and tracheostomies to qualified and credentialed personnel


name: Assist with insertion of an ET by gathering necessary intubation and emergency equipment, positioning patient, administering medications as ordered, and monitoring the patient for complications during insertion


name: Mark ET at the position of the lips or nares, using the centimeter markings on the ET, and document


name: Determine if breathing absent or inadequate


name: Use hand hygiene and personal protective equipment (PPE) (e.g., gloves, goggles, mask, face shield), as appropriate


name: Provide rescue breaths using available equipment (e.g., one-way valve CPR mask, bag mask) if breathing absent


name: Determine cause of airway patency issue (e.g., cardiac arrest, drug overdose, upper airway obstruction, trauma, lung disease, congestive heart failure)


name: Remove foreign bodies from airway if visible


name: Ensure rescue breath volume associated with chest rise


name: Administer intramuscular or intranasal naloxone for person with known or suspected opioid overdose-induced respiratory arrest, as appropriate


name: Insert artificial airway device (e.g., oral, nasopharyngeal, tracheal), as appropriate


name: Position to maximize ventilation potential (i.e., position to alleviate dyspnea)


name: Remove secretions through appropriate means (e.g., coughing; suctioning of oropharynx, nasopharynx, trachea, endotracheal areas)


name: Use age appropriate and interactive techniques to encourage deep breathing for children (e.g., blow bubbles with bubble blower; blow on pinwheel, balloons, party blowers; feathers)


name: Administer bronchodilators or other treatments via aerosol treatments or ultrasonic nebulizer treatments, as prescribed


name: Instruct how to use prescribed respiratory treatments, as appropriate


name: Document all allergies in clinical record, according to policy


name: Place allergy band on person, as appropriate


name: Monitor for allergic reactions to new medications, formulas, foods, latex, and test dyes


name: Monitor after exposures to agents known to cause allergic responses, for signs of generalized flush, angioedema, urticaria, paroxysmal coughing, severe anxiety, dyspnea, wheezing, orthopnea, vomiting, cyanosis, or shock


name: Observe for 30 minutes after administration of agent known to be capable of inducing allergic response


name: Determine level of threat allergic reaction presents to health status


name: Provide medication to reduce or minimize allergic response


name: Encourage to wear medical alert tab, as appropriate


name: Instruct person with new medication prescriptions to monitor for potential allergic reactions


name: Instruct how to read food labels for hidden ingredients


name: Instruct how to treat rashes, vomiting, diarrhea, or respiratory problems


name: Instruct how to avoid allergens, situations, or substances that cause risk


name: Instruct how to respond if anaphylactic reaction occurs


name: Encourage use of healthy coping strategies (e.g., problem-solving, seeking information, sharing feelings)


name: Calibrate and flush catheter after placement


name: Infuse isotonic IV solution rapidly into uterine cavity, as prescribed


name: Lower head of bed 15 to 30 degrees or place supine with feet elevated higher than heart level


name: Determine patient's previous response to analgesics (e.g., if non-opioid medication as effective as opioid)


name: Assure appropriateness of opioid dosage (e.g., large doses acceptable in opioid-tolerant patients but not opioid-naïve patients)


name: Provide adjunct medications for pain relief (e.g., antidepressants, anticonvulsants, and nonsteroidal anti-inflammatory agents), as appropriate


name: Perform rapid evaluation of airway, breathing, circulation, and mental status


name: Administer solution of epinephrine, 1:1000, intramuscular (preferred) or subcutaneously, dosing appropriate for age


name: Provide continuous monitoring of mental status, vital signs, and medication administration


name: Place in position of comfort (may need to elevate lower extremities, depending on vital signs)


name: Administer high-flow supplemental oxygen (6-8 L/min) via facemask


name: Establish IV access using 0.9% (isotonic) saline


name: Administer IV fluids rapidly (e.g., 1000 mL/hr) to support blood pressure, per health care provider order or protocol


name: Administer secondary medications (e.g., beta-2 adrenergic agonists, antihistamines, corticosteroids), as indicated if urticaria, angioedema, or bronchospasm present


name: Instruct on medication management (e.g., epinephrine injection pen, antihistamine, corticosteroids)


name: Instruct on prevention of future episodes (e.g., allergen testing)


name: Instruct on importance of medical identification


name: Include family in instruction, as appropriate


name: Determine person's acceptance of animals as therapeutic agents


name: Explain purpose and rationale for having animals in care environment


name: Enforce standards for screening, training, health maintenance, and grooming of animals in therapy program


name: Fulfill health department regulations concerning animals in institution


name: Develop policy or protocol that outlines appropriate response to accident or injury as result of animal contact


name: Wash hands before and after handling pet


name: Avoid animal visits with unpredictable or violent persons


name: Monitor animal visits with persons with special conditions (e.g., open wounds, delicate skin, multiple IV lines, other equipment)


name: Facilitate person's holding and petting therapy animals


name: Encourage interactions with therapy animal (e.g., petting, feeding, grooming)


name: Note response to interactions with therapy animals


name: Provide opportunity to reminisce and share previous experiences with pets or other animals


name: Identify verbal and nonverbal signs of anxiety


name: Seek to understand person's perspective of stressful situations


name: Provide information concerning diagnosis, treatment, and prognosis


name: Stay with person to promote safety and reduce anxiety


name: Encourage family to stay with person, as appropriate


name: Administer back and neck massage, as appropriate


name: Help identify situations that precipitate anxiety


name: Support use of appropriate psychological defense mechanisms


name: Assist to articulate realistic description of upcoming event


name: Instruct on use of relaxation techniques (e.g., guided imagery, music, massage, aroma therapy, art therapy, yoga, Tai Chi)


name: Suggest use of phone apps and virtual immerse reality technology that promotes relaxation


name: Administer essential oil using appropriate methods (e.g., topical, inhalation)


name: Determine individual response to selected aroma before use


name: Instruct in use of essential oils, mode of action, and any contraindications


name: Dilute essential oils with appropriate carrier oils before topical use, as needed


name: Avoid prolonged use of same essential oil or repeated topical application to same site


name: Ensure adequate ventilation when using essential oils


name: Instruct on purposes and application of aromatherapy, as appropriate


name: Monitor for level of stress, mood, and anxiety before and after aromatherapy


name: Obtain spirometry measurements (e.g., FEV1, FVC, FEV1/FVC ratio) at diagnosis, initially with use of short-acting bronchodilator, and as needed


name: Auscultate breath sounds, noting areas of decreased or absent ventilation and adventitious sounds


name: Administer medication, as appropriate and per policy and procedural guidelines


name: Auscultate breath sounds after treatment to determine results


name: Instruct on breathing and relaxation techniques


name: Use calm, reassuring approach during asthma attack


name: Determine understanding of condition and management


name: Instruct on anti-inflammatory and bronchodilator medications and their appropriate usage


name: Instruct on proper techniques for using medication and equipment (e.g., inhaler, nebulizer, peak flow meter, spacer)


name: Instruct on proper cleaning of medication administration equipment


name: Determine concordance with prescribed treatments


name: Review coping strategies for enhanced self-management and care decision making


name: Identify possible triggers (e.g., environmental allergens, animals, medication, food, exercise, temperature, emotions, other medical conditions) and usual reaction


name: Instruct to identify and avoid triggers, as possible


name: Establish written asthma treatment plan with person for managing exacerbations and encourage to distribute to additional caregivers (e.g., day care, school nurse, athletic coach) as appropriate


name: Assist in recognition of signs or symptoms of impending asthmatic reaction and implementation of appropriate response measures


name: Identify symptoms that may indicate need for change in therapy


name: Inform person and family about policy and procedures for carrying and administration of asthma medications at school


name: Inform parent and guardian when child has needed or used PRN medication in school, as appropriate


name: Establish regular schedule of follow-up care


name: Prescribe and renew asthma medications, as appropriate


name: Foster self-management of asthma as child increases in age and maturity


name: Consider culture and age when promoting bathing activities


name: Determine amount and type of assistance needed (e.g., complete bed bath, partial bath, bag bath, towel bath, tub bath, shower)


name: Explain process of using warmed, packaged no-rinse cleanser or antimicrobial cleanser as indicated


name: Provide desired personal articles (e.g., towel, deodorant, bath soap, shampoo, lotion, aromatherapy products)


name: Provide therapeutic environment by ensuring warm, relaxing, private, and personalized experience


name: Use safety strips in tub, and rubber bathmats or towels on floor to prevent slippage


name: Cover all intravenous catheters or wound dressings with plastic, as indicated


name: Assist with cleansing back, lower legs, and feet as indicated


name: Cleanse from clean areas to dirty areas (i.e., chest to perineal area)


name: Wash and comb hair and shave, as needed and desired


name: Bathe in water of comfortable temperature


name: Encourage parent or family participation in usual bedtime rituals, as appropriate


name: Use fun bathing techniques with children (e.g., wash dolls or toys; pretend boat is submarine; punch holes in bottom of plastic cup, fill with water, and let it "rain" on child)


name: Facilitate maintenance of usual bedtime routines, pre-sleep cues or props, and familiar objects (e.g., for children, a favorite blanket or toy, rocking, pacifier, or story; for adults, book to read or pillow from home), as appropriate


name: Apply lubricating lotion and cream to dry skin areas


name: Apply drying powders to deep skin folds sparingly to avoid caking and respiratory irritation


name: Assist with entering or exiting tub or shower, as needed


name: Promote psychosocial well-being by conversing during bathing


name: Facilitate bathing self, shaving and washing or combing hair, as appropriate


name: Monitor cleaning of nails, according to self-care ability


name: Provide assistance until fully able to assume self-care


name: Facilitate assistance of a barber or beautician, as needed


name: Document tolerance of procedure, as indicated


name: Assist in identifying behavior and desire to change


name: Assist to identify own strengths and abilities


name: Avoid focusing on diagnosis or disease process when assisting in identifying goals


name: Assist in identifying realistic, attainable goals


name: Assist in identifying appropriate short-term and long-term goals, in easily observed behaviors and positive terms


name: Encourage to write down goals, if possible


name: Clarify roles of health care provider and individual respectively


name: Explore resources and methods to achieve goals


name: Assist in identifying and overcoming barriers


name: Explore methods for evaluating accomplishment of goals


name: Facilitate making written contract, including all agreed-upon elements


name: Assist in setting time or frequency requirements for performance of behaviors and actions


name: Identify target date for termination of contract


name: Coordinate opportunities for review of contract and goals


name: Assist in discussing feelings about contract


name: Observe for signs of incongruence and lack of commitment to fulfilling contract


name: Identify consequences or sanctions for not fulfilling contract, if desired


name: Provide copy of signed and dated contract


name: Encourage to identify appropriate, meaningful reinforcers or rewards


name: Encourage to choose reinforcer or reward that sustains behavior


name: Specify timing of delivery of reinforcers or rewards


name: Instruct on various methods of observing and recording behaviors


name: Assist in developing flowchart to assist in tracking progress toward goals


name: Consult with family to establish individual's pattern of undesired behaviors


name: Determine why, when, and how undesired behavior occurring


name: Identify events that trigger or maintain problem behavior


name: Hold individual responsible for behavior


name: Set limits on negative behavior with individual


name: Communicate expectation that individual will retain control


name: Develop specific sequence of steps associated with instruction


name: Provide positive reinforcement as meets each specific expectation


name: Use positive reinforcement to increase desired behavior


name: Consider using shaping strategies (i.e., gradually foster development of new behavior by repetitively reinforcing minor improvements or steps toward desired behaviors)


name: Create situations for individual to imitate modeled behavior


name: Provide positive reinforcement if models desired behavior


name: Refrain from giving positive reinforcement if does not model desired behavior


name: Establish consistency in environment and care routines


name: Use consistent repetition of health routines as means of establishing routines


name: Apply restraints to prevent self-harm or harm to others, per agency protocol


name: Identify undesired inattentive or hyperactive behavior


name: Consult with family to establish individual's pattern of inattentive or hyperactive behavior


name: Determine factors that trigger or maintain undesired inattentive and hyperactive behavior


name: Identify factors that de-escalate inattentive and hyperactive behavior


name: Determine appropriate behavioral expectations and consequences, given individual's level of cognitive functioning and capacity for self-control


name: Provide structured and physically safe environment


name: Use calm, matter-of-fact, reassuring approach


name: Develop evidence-based behavioral management plan carried out consistently by all care providers


name: Provide reassurance that staff will assist individual with managing behavior, as necessary


name: Obtain individual's attention before initiating verbal interactions (e.g., call by name, obtain eye contact)


name: Ask individual to repeat instructions before beginning activities


name: Divide multiple-step instructions into simple steps


name: Allow individual to carry out one step before being given another


name: Provide assistance to complete activities, as necessary


name: Provide aids to increase environmental structure, concentration, and attention to activities (e.g., watches, calendars, signs, step-by-step written instructions)


name: Maintain routine schedule that includes balance of structured time (e.g., physical and nonphysical activities) and quiet time


name: Redirect or remove from source of overstimulation (e.g., peer, problem situation)


name: Use external controls to calm individual (e.g., time out, seclusion, physical restraint), when necessary


name: Monitor physical status of hyperactive individual (e.g., body weight, hydration, condition of feet in individual who paces)


name: Encourage expression of feelings in appropriate manner


name: Provide information about illness (e.g., attention deficit disorder, hyperactivity, mania, schizophrenia) to individual and significant others, as appropriate


name: Monitor individual for medication side effects and desired behavioral outcomes


name: Provide medication instruction to individual and significant others


name: Use alternative therapies to promote desired behaviors, as appropriate


name: Facilitate reasonable behavioral expectations for individual with family and significant others


name: Assist individual and involved others (e.g., family, employers, teachers) to adapt home, work, or school environments to accommodate limitations imposed by chronic inattention and hyperactivity


name: Collaborate with providers in schools and others in community to enhance treatment management


name: Identify previous history of self-mutilating behaviors or self-abusive behaviors


name: Develop appropriate behavioral expectations and consequences based on level of cognitive functioning and capacity for self-control


name: Communicate behavioral expectations and consequences to person


name: Monitor for self-harmful impulses that may progress to suicidal thoughts or gestures


name: Use calm, nonpunitive approach when dealing with self-harmful behaviors


name: Assist to identify situations and feelings that may prompt self-harm or that prompted self-harmful behavior


name: Assist to identify more appropriate coping strategies and consequences


name: Contract for "no self-harm" to enable person to stay physically safe


name: Provide ongoing surveillance of person and environment


name: Provide close one-to-one observation of person when necessary to maintain safety


name: Encourage to seek out care providers to talk as urge to harm self occurs


name: Formulate plan of care with person including goals for preventing undesired self-harm behaviors


name: Suggest alternative behaviors, such as seeking interpersonal support or engaging in adaptive anxiety-reducing activity


name: Instruct about coping strategies (e.g., assertiveness training, impulse control training, progressive muscle relaxation), as appropriate


name: Use behavior management techniques (e.g., differential reinforcement, extinction, response interruption, redirection), as appropriate


name: Involve in individual and group therapies, as appropriate


name: Provide medication instructions to person and significant others


name: Provide predetermined consequences if engaging in self-harmful behaviors


name: Place in more protective environment (e.g., area restriction, seclusion) if self-harmful impulses and behaviors escalate


name: Assist to assume responsibility for consequences of behavior (e.g., dress own self-inflicted wound)


name: Provide care for wounds in neutral, matter of fact manner by refraining from punitive or overly sympathetic response, or providing additional attention


name: Provide family or significant others with guidelines to manage self-harmful behavior outside care environment


name: Provide illness teaching to person or significant others if self-harmful behavior is illness-based (e.g., borderline personality disorder, autism)


name: Reinforce positive behaviors that decrease or eliminate self-mutilating or self-abusive behaviors


name: Develop plan for safety with person to effectively deal with precursors to undesired behavior when in home environment


name: Identify sexual behaviors that are unacceptable given particular setting and population (e.g., inappropriate remarks in public places, inappropriate statements to people they know; unwanted advances; touches, hugs, or kisses another more than appropriate; attempts to have sexual intercourse with others; exposes self or masturbates in public)


name: Discuss consequences of socially unacceptable sexual behavior and verbalizations


name: Discuss, based on developmental and cognitive ability, negative impact that socially unacceptable sexual behavior may have on others, as appropriate


name: Assign to private room if assessed to be high risk for socially unacceptable sexual behavior


name: Limit physical mobility to decrease opportunity for socially unacceptable sexual behaviors, as needed


name: Provide appropriate level of supervision to monitor person


name: Use calm, matter-of-fact approach when responding to socially unacceptable sexual remarks and behavior


name: Discuss why sexual behavior or verbalization unacceptable


name: Explore intentions behind each behavior to address cognitive distortions, and negative conditioning techniques


name: Discuss acceptable ways to fulfill individual sexual needs in privacy


name: Discourage initiation of sexual or intimate relationships while under severe stress


name: Provide counseling for persons who have been sexually abused, as needed


name: Consider pharmacologic treatment, as needed


name: Provide opportunities for staff to process feelings about socially unacceptable sexual behavior


name: Assist to identify strengths, and reinforce these


name: Separate behaviors to be changed into smaller, measurable units of behavior (e.g., stopping smoking; number of cigarettes smoked)


name: Consider that it is easier to increase behavior than to decrease behavior


name: Establish baseline occurrence of behavior before initiating change


name: Develop method (e.g., graph or chart) for recording behavior and changes


name: Introduce to persons and groups who have successfully undergone same experience


name: Ensure consistency implementing strategies for change by all staff


name: Provide feedback when free of symptoms and looks relaxed


name: Avoid showing rejection or belittlement during struggles with changing behavior


name: Offer positive reinforcement for independently made decisions


name: Assist in identifying even small successes


name: Encourage to participate in monitoring and recording behaviors


name: Discuss behavior modification process with all involved persons


name: Develop treatment contract to support implementation of token or point system


name: Administer positive reinforcers on predetermined schedule (continuous or intermittent) for desired behaviors


name: Withdraw positive reinforcers from undesired behaviors, and attach reinforcers to more desirable replacement behavior


name: Encourage to participate in selection of meaningful reinforcers


name: Coordinate token or point system of reinforcement for complex or multiple behaviors


name: Ask to tell their story related to interpersonal behavioral problems


name: Help identify behavioral problems that results from the way a person relates to others


name: Use behavioral evidence-based interpersonal skills training program


name: Encourage sharing of feelings (negative and positive) that occur related to these interpersonal problems


name: Assist to identify desired outcomes or goals for problematic interpersonal relationships or situations


name: Assist to determine if desired goals are realistic and attainable, or if better goals are needed


name: Assist to identify possible courses of action and their social or interpersonal consequences, including changes they are likely to experience because of new relationship goals


name: Help identify changes a person is willing to make to meet new interpersonal goals


name: Assist to identify behavioral steps for targeted social skills that include changes person willing to make


name: Provide methods (e.g., role play, video presentation) demonstrating behavioral steps in context of situations that are meaningful


name: Assist to role play behavioral steps if comfortable in role play


name: Involve significant others in social skills training sessions (e.g., role play), as appropriate


name: Provide feedback (e.g., praise or rewards) about performance of targeted social skills


name: Educate significant others (e.g., family, peers, employers) about purpose and process of social skills training, as appropriate


name: Provide feedback about appropriateness of social responses in training situations


name: Provide educational materials to assist understanding of interpersonal changes that will help meet goals, including educational material using role playing, videos, or written information


name: Encourage to self-evaluate outcomes of social interactions, self-reward for positive outcomes, and problem-solve less desirable outcomes


name: Facilitate spiritual support for family and significant others, as appropriate


name: Create supportive therapeutic environment


name: Encourage sharing and expressing feelings and emotions


name: Provide anticipatory guidance for feelings of grief and loss


name: Assist to identify shared meaning of loss


name: Support individual family members through personal stages of grief


name: Encourage implementation of cultural, religious, and social customs


name: Accept culturally diverse grief responses


name: Offer to facilitate discussion of memorial arrangements (e.g., military honor, contacting religious leader)


name: Assist with referral to bereavement services


name: Express condolence in appropriate manner (e.g., sending card, attending memorial service, telephone call)


name: Develop response plan for types of chemical and biological agents that are likely terrorism agents (e.g., nerve agents, mustard agents, cyanide, anthrax, smallpox, botulism, plague)


name: Identify notification priorities for each type of potential agent


name: Ensure access to required contact numbers (e.g., internal infection control personnel, epidemiologist, healthcare facility administration, local, state, federal health agencies, federal and local police, disease control agency, medical emergency services)


name: Ensure response plan include details for management of both types of potential scenarios (e.g., covert event bioterrorism outbreak, announced bioterrorism events or threats)


name: Seek assistance of government health officials to determine type of event


name: Follow instructions regarding screening persons during bioterrorism event, using pre-designed syndrome-based criteria to identify potential outbreaks


name: Use epidemiologic principles to determine unusual outbreak versus endemic disease (e.g., clusters of persons arriving from single locale, rapidly increasing disease incidence, large numbers of rapidly fatal cases)


name: Use current WHO and CDC recommended strategies to contain natural or deliberate disease and chemical events


name: Ensure personnel are familiar with signs, symptoms, and common onset presentations of persons exposed to bioterrorism agents


name: Modify initial assessment questions and history to be inclusive of exposure risk and physical symptoms of exposure


name: Monitor persons with vague yet possibly significant symptoms (e.g., flu-like)


name: Ensure regular staff training for protective equipment, protective procedures, and isolation techniques


name: Ensure that protective equipment (e.g., hazmat suits, headgear, gloves, respirators) available and in good working order


name: Ensure all staff are familiar with and follow all decontamination policies, procedures, and protocols


name: Provide continuing staff education to maintain up-to-date knowledge


name: Ensure regular training including simulations for all staff


name: Avoid administering medications that will further compromise clotting times (e.g., clopidogrel, heparin, warfarin, or nonsteroidal anti-inflammatory drugs [NSAIDs] such as aspirin)


name: Instruct patient to avoid medications that will further compromise clotting times (e.g., clopidogrel, heparin, warfarin, or non-steroidal anti-inflammatory drugs [NSAIDs] such as aspirin), as appropriate


name: Initiate fetal resuscitation for abnormal (non-reassuring) signs of uteroplacental insufficiency


name: Instruct the patient and/or family to avoid the use of anti-inflammatory medications (e.g., aspirin and ibuprofen)


name: Review obstetrical history and labor record for risk factors for postpartum hemorrhage (e.g., prior history of postpartum hemorrhage, overdistention of the uterus, rapid labor, prolonged third stage, uterine infection, lacerations, retained placenta, labor, induction, use of anesthesia, preeclampsia, prolonged second stage, assistive birth, cesarean birth, or precipitous birth)


name: Verify that blood product has been prepared, typed, and cross-matched (if applicable)


name: Verify correct person, blood type, Rh type, unit number, and expiration date with two licensed personnel


name: Instruct related to risks, benefits, and alternatives to transfusion


name: Instruct about signs and symptoms of transfusion reactions (e.g., dizziness, chest pain, pruritus, papules, skin rash, dyspnea, choking sensation, abdominal pain, back pain, hematuria)


name: Ensure good venous access before obtaining blood products


name: Provide dedicated IV line and adequate gauge IV catheter for blood infusion


name: Prepare IV pump approved for blood product administration, if indicated


name: Initiate blood transfusion no later than 30 minutes after removal from blood bank


name: Avoid transfusion of more than one unit of blood, blood component, or blood product at a time, unless necessitated by recipient's condition


name: Monitor condition and vital signs (e.g., baseline, throughout and after transfusion)


name: Monitor for transfusion reactions (e.g., fever, chills, tremors, increase of 1ºC from initial temperature)


name: Refrain from transfusing blood product removed from controlled refrigeration over more than 4 hours.


name: Administer saline when transfusion complete


name: Obtain blood sample and first voided urine specimen after transfusion reaction


name: Coordinate return of blood container and tubing to laboratory after blood reaction


name: Notify laboratory immediately in event of blood reaction


name: Document transfusion reaction and condition of recipient per agency policy


name: Determine body image expectations based on developmental stage


name: Use anticipatory guidance to prepare for predictable changes in body image


name: Determine whether perceived dislike for certain physical characteristics creates dysfunctional social paralysis for teenagers and other high-risk groups


name: Assist to discuss changes caused by illness or surgery, as appropriate


name: Help determine extent of actual changes in body or level of functioning


name: Determine whether recent physical change has been incorporated into body image


name: Assist to separate physical appearance from feelings of personal worth, as appropriate


name: Discuss changes caused by puberty, as appropriate


name: Discuss cognitions (e.g., irrational beliefs, dichotomous thinking, automatic thoughts, cognitive errors) and role in feelings and behaviors related to body image


name: Discuss changes caused by normal pregnancy, as appropriate


name: Discuss changes caused by aging, as appropriate


name: Determine person's and family's perceptions of alteration in body image versus reality


name: Instruct about normal changes in body associated with various stages of aging, as appropriate


name: Determine whether change in body image has contributed to increased social isolation


name: Discuss stressors affecting body image due to congenital condition, injury, disease, or surgery


name: Identify effects of culture, religion, race, sex, gender, and age in terms of body image


name: Monitor whether person can look at changed body part


name: Discuss how negative body image expressed in various behaviors (e.g., body checking, weighing, measuring, pinching, mirror checking), body avoidance (e.g., avoiding mirrors, wearing baggy clothing) or appearance preoccupation (i.e., time-consuming efforts to groom, manage, or alter appearance)


name: Instruct how to self-monitor and restructure thoughts using log, journal, or diary


name: Instruct how to change and improve use of negative body image language to describe body (e.g., "I have a disgusting belly") to non-judgmental and fact-based statements like "I have a round belly"


name: Instruct to focus attention less on disliked body parts toward more attention on other body parts and on seeing body as a whole


name: Conduct guided imagery exercises designed to focus and direct imagination to relive important event that influenced body image


name: Discuss eating disorders and related behaviors and cognitions, including risk factors for developing eating disorder, unhealthy eating patterns (e.g., binging, fasting, dietary restraint, excessive exercising)


name: Use exposure exercises with goal of gradually extinguishing negative body image reactions and situations (i.e., mirror exposure to expose participants to own body)


name: Create and agree on verbal or written contract with specific tasks


name: Identify barriers to performing specific behavior and plan ways of overcoming them


name: Provide feedback about behaviors or performance on task


name: Provide encouragement regarding continued performance of cognitive or behavioral exercises designed to improve body image perceptions


name: Discuss concept of stress, what stress is (e.g., healthy vs. unhealthy forms), what causes stress, and consequences of stress for health and well-being


name: Use stress management techniques that do not target body image cognition and behaviors but seek to reduce anxiety and stress (e.g., progressive muscle relaxation, deep breathing)


name: Provide information about alternative help resources (e.g., self-help books, websites, social media, support group)


name: Discuss causes for negative body image (e.g., media influence, receiving specific negative remarks or teasing about one's weight, internal need for perfectionism)


name: Provide media literacy training to help decipher media messages that set unrealistic images of beauty critical of body types


name: Discuss stereotypes, prejudice, and discrimination related to gender or appearance (e.g., stereotypes about women or men, thin or overweight people, impact of prejudice and discrimination on body image)


name: Assist in use of strategies designed to resist impact of media (e.g., avoid negative sources)


name: Provide alternative empowering images of women or men that go against current beauty ideal


name: Discuss concept of self-esteem, how self-esteem formed, what factors influence self-esteem, how self-esteem relates to well-being


name: Provide self-esteem enhancement exercises designed to enhance positive self-regard. (i.e., write list of talents and positive personality traits)


name: Discuss physical activity and its role in promoting healthy body image


name: Discuss interpersonal relations that impact on body images (e.g., peer pressure, social rejection, unacceptability, and impact of appearance-based teasing, effects of fat talk)


name: Instruct on use of interpersonal skills designed to enhance communication with others (e.g., express opinions, how to resolve interpersonal conflicts)


name: Provide mindfulness exercises designed to promote positive body image (e.g., deep breathing, body scan, meditation, mindful eating)


name: Discuss psychological consequences of negative body image, such as development of eating disorder, depression, low self-esteem, social anxiety


name: Instruct on importance of child's responses to body changes and future adjustment, as appropriate


name: Assist to identify feelings before intervening with child, as appropriate


name: Assist in identifying parts of body that have positive perceptions associated with them


name: Assist to identify actions that will enhance appearance


name: Assist hospitalized person to apply cosmetics before seeing visitors, as appropriate


name: Determine reason for search (e.g., harm to self, harm to others, possession of unlawful substances)


name: Follow agency policies that permit conducting body searches (e.g., have health care provider order, documented need for search)


name: Create list of unsafe items not allowed on unit or care area and ensure list accessible to all persons and visitors entering care area (e.g., signs)


name: Provide knowledge of rights and responsibilities when admitted, including possibility of body search


name: Ask person if in possession of any items not allowed in care area and to give items to personnel


name: Inform of legal rights before initiating search


name: Inform of pattern of search as well as what will be examined during search


name: Provide information about search in language and format that allows adequate comprehension


name: Determine when to conduct search (e.g., at the time of admission, upon return from leaves of absence, when deemed necessary)


name: Use PPE and safety equipment during search, when necessary


name: Establish pattern of search (i.e., search clothing first, followed by personal belongings and ending with external body)


name: Observe for inappropriate bulges or areas person reluctant to reveal


name: Avoid conversation or distracting activities during search


name: Provide for adequate comfort and privacy during search (i.e., provide for person of same gender to be present or perform search)


name: Remove all contraband obtained during searches for safekeeping according to agency policy


name: Ask visitors to give prohibited items to personnel for safekeeping


name: Review each situation individually, ensuring body searches conducted only when necessary


name: Document searches in detail, including need for search and items found


name: Document placement or storage of any items retrieved during search


name: Determine infant sleep and wakefulness patterns before initiating feeding


name: Warm fluid to room temperature before feeding


name: Position infant with support in semi-Fowler's position for feeding


name: Control intake by regulating softness of nipple and size of hole and bottle


name: Provide chin support to decrease leaking of fluid and improve lip closure


name: Instruct on sterilization techniques for feeding equipment


name: Instruct on proper dilution of concentrated formula


name: Instruct on proper storage of breast milk


name: Instruct on not forcing termination of liquid intake


name: Caution about using microwave oven to warm formula


name: Demonstrate oral hygiene techniques appropriate to infant's dentition to be used after each feeding


name: Discuss alternatives to bedtime bottle to prevent bottle caries


name: Review health history including diagnoses, surgeries, and bowel habits


name: Identify factors that affect bowel habits (e.g., medications, exercise, sleep, stress, smoking, diet, toilet access)


name: Note pre-existing bowel problems, bowel routine, and use of laxatives and enemas


name: Monitor bowel movements including frequency, consistency, volume, and color, as appropriate


name: Determine physical, cognitive, and psychological cause of fecal incontinence


name: Eliminate cause of incontinence (e.g., medication, diet, infection, fecal impaction), if possible


name: Develop bowel management program (e.g., procedure, outcomes)


name: Instruct to record fecal output, as appropriate


name: Monitor perineal skin for redness, itching, pain, pressure injury, and infection


name: Wash perianal area and dry thoroughly after each stool (e.g., soap and water, nonionic detergent)


name: Protect skin from excess moisture with barrier cream (e.g., lanolin, dimethicone), as prescribed


name: Avoid powder and creams on perineal area unless prescribed


name: Instruct to avoid foods that cause diarrhea


name: Administer prescribed medication for diarrhea (e.g., loper-amide, atropine)


name: Use rectal tube, anal plug device, or fecal collection device, per protocol


name: Provide incontinent pants and pads as needed


name: Identify factors that affect bowel habits (e.g., medications, exercise, sleep, stress, smoking, diet)


name: Monitor bowel movements including date, frequency, consistency, volume, shape, and color, as appropriate


name: Monitor for signs and symptoms of diarrhea, constipation, and impaction (e.g., quality of bowel sounds, frequency and consistency of stools)


name: Instruct about specific foods that are assistive in promoting bowel regularity


name: Instruct to record frequency, consistency, volume, shape, and color of stools


name: Use rectal suppository, enema, or digital rectal dilatation as appropriate


name: Initiate individualized bowel training program, as appropriate


name: Instruct on principles of bowel training


name: Initiate uninterrupted, consistent scheduled time for defecation


name: Instruct on health bowel habits (e.g., avoid straining, proper positioning on toilet)


name: Instruct on foods high in fiber, as appropriate


name: Explore possible risk factors for development of breast cancer (e.g., current age, age at first pregnancy, age at menarche, age at menopause, family history, history of breast disease, parity status, history of breastfeeding)


name: Determine if pain, lump, thickening, or tenderness; discharge, distortion, retraction, or scaling of nipple is present


name: Assist to positions of comfort as examination proceeds, allowing privacy and sensitivity


name: Explain each specific step of examination


name: Conduct examination in upright then supine position


name: Instruct to remove gown or chest covering


name: Note symmetry and contour of breasts and position of nipples bilaterally, for deviation or abnormality


name: Instruct to utilize four different positions for visual inspection (e.g., arms at side, hands at waist and push inward toward hips, hands behind the head, and arms across waist with chest falling forward)


name: Check for nipple discharge by gently squeezing each nipple


name: Inspect and palpate lymph node chains, including supraclavicular, infraclavicular, lateral, central, subscapular, and anterior nodes, for abnormalities


name: Place small pillow or towel under shoulder blade of breast to be examined, abduct arm on same side of breast, and place person's hand behind her head


name: Using systematic approach, palpate breast tissue with palmar surface of first three fingers of examiner's dominant hand


name: Move in rotary fashion and compress breast tissue against chest wall


name: Check for masses, including location, shape, size (in cm), tenderness, mobility, and consistency


name: Observe mastectomy scar site for presence of rash, edema, thickening, or erythema, as appropriate


name: Report abnormalities to health care provider or nurse, as appropriate


name: Encourage to demonstrate self-palpation during and after clinical breast examination


name: Instruct about importance of regular breast self-examination, need to be familiar with how own breasts normally look and feel, and report any changes to health care provider


name: Advise regular mammograms as appropriate for age, condition, history, ethnicity, race, diet, activity, and presence of risk factors


name: Minimize anxiety using age-appropriate procedures


name: Offer pain relief measure before venipuncture or capillary heel-pricks


name: Warm site for approximately 5 minutes if arterialized sample, per agency protocol


name: Use aseptic technique during skin puncture, per agency protocol


name: Select length of lancet according to age (e.g., 0.85 mm for infants or young child, 2.2 mm for older child or adults)


name: Puncture outer aspect of heel no deeper than 1.5 mm for child over 6 months but below 8 years, and up to 2.4 mm for child over 8 years


name: Puncture skin with one quick, continuous, and deliberate stroke, with lancet or approved penetration device, per manufacturer's specifications


name: Wipe off first drop of blood with dry gauze


name: Collect blood in manner appropriate to test being performed (e.g., allow drop of blood to fall onto manufacturer's specified area of filter paper or test strips, draw blood into tubes by capillary action as droplets form)


name: Instruct and monitor for self-sampling capillary blood, as appropriate


name: Monitor ECG for ST segment changes, as appropriate


name: Determine level of knowledge, capability, and limitations


name: Provide information about condition, treatment, and care in accordance with care recipient preferences


name: Monitor stress and encourage coping strategies


name: Instruct on stress management techniques and health care maintenance strategies


name: Encourage participation in support groups, social networking, community, and online resources


name: Offer to provide care for short periods, if experiencing difficulties or increased stress


name: Identify attitude and personal feelings toward person and situation


name: Determine ethical boundaries of relationship


name: Create climate of warmth, caring, and unconditional acceptance


name: Discuss responsibilities in relationship and set limits of acceptable behavior, as appropriate


name: Return at established time to demonstrate trustworthiness and interest


name: Establish open body posture, physical distance, and appropriate nonverbal expressions


name: Monitor person's nonverbal communication


name: Respond to nonverbal messages, as appropriate


name: Identify readiness to explore identified problems and develop strategies for change


name: Reflect main ideas and return conversation to main subject, as needed


name: Encourage introspection and behavioral change


name: Encourage to take time needed to express self


name: Assist to identify feelings that impede ability to interact with others (e.g., anger, anxiety, hostility, sadness)


name: Develop alternative ways of communicating (e.g., images, other words), as needed


name: Listen actively to concerns and discussions


name: Assist to identify areas of need to be addressed during meetings


name: Support efforts to interact with others in positive manner


name: Facilitate attempts to review therapeutic relationship experiences


name: Use summary as starting point for future conversations


name: Identify individuals or populations who would benefit from case management (e.g., high cost, high volume, high risk)


name: Explain cost of service before providing care


name: Obtain permission to be enrolled in case management program, as indicated


name: Develop relationships with person, family, and other health care providers, as needed


name: Evaluate physical health status, mental status, functional capability, formal and informal support systems, financial resources, and home environment, as needed


name: Individualize treatment plan and intended outcomes with input from person and family


name: Explain plan of care to person and family


name: Validate desired outcomes with person and family


name: Discuss plan of care and intended outcomes with health care provider


name: Integrate care management information and revised interventions into handoff report and group practice meetings, as needed


name: Evaluate progress toward established goals


name: Revise interventions and goals to meet needs, as necessary


name: Coordinate care with other pertinent health care providers (e.g., primary care providers, nurses, advanced practice nurses, physicians, social workers, pharmacists, physical therapists, third-party payers)


name: Encourage appropriate decision-making activities


name: Monitor plan of care for quality, quantity, timeliness, and effectiveness of services


name: Assist with access to health care delivery system


name: Guide through health care delivery system


name: Assist in making informed decisions regarding health care


name: Include clinical and financial concerns in decision-making


name: Notify of change in service, termination of service, or discharge from case management program


name: Modify care to reduce cost, as indicated


name: Market case management services to individuals, families, insurers, and employers


name: Address compromised circulation and pain symptoms immediately (e.g., reposition cast, perform ROM to extremity, immediate cast pressure-relieving action)


name: Determine agency guidelines, protocols, policies, and procedures


name: Determine understanding of purpose, care, and maintenance of catheter


name: Provide information related to catheter (e.g., indications, functions, type of device to be used, care of device, potential complications, insertion procedure)


name: Avoid use until confirmation of tip placement post-implantation with baseline chest x-ray


name: Employ strict aseptic technique whenever catheter handled, accessed, or used to administer medications, to reduce potential for central line associated blood stream infections (CLABSIs)


name: Check patency immediately before administering prescribed medications or infusions, per agency protocol


name: Employ actions to ensure patency per agency protocol for occluded devices


name: Use smaller gauge silastic catheters to administer medications


name: Change clear fluid administration sets per agency policy


name: Record site care and fluid administration


name: Avoid catheter insertion near stoma or areas such as diapers where contact with fecal material may occur


name: Cleanse site and apply dressing per agency protocol


name: Monitor for complications (e.g., pneumothorax, cardiac tamponade, arterial puncture, hemorrhage, hemothorax, hydro-thorax, air embolus, brachial nerve plexus injury, thoracic duct injury, infection, misplacement)


name: Inspect entry site daily for redness, pain, tenderness, warmth, or swelling


name: Report signs of inflammation, leakage, or discharge to health care provider


name: Apply firm pressure and appropriate dressing to puncture site after removing catheter, per agency protocol


name: Ensure documentation of manufacturer, model number, serial number, and implant date


name: Report adverse signs and symptoms (e.g., tachycardia, hypotension, dyspnea, agitation, independent filling of access needle with fluid or blood, shoulder or back pain, cardiac arrest)


name: Instruct to wear medical alert bracelet or necklace that identifies device


name: Identify intended use of catheter to determine type needed (i.e., central or midline catheter)


name: Explain purpose, benefits, and risks associated with use


name: Select appropriate size and type of catheter to meet needs


name: Select most accessible and least used vein available, usually basilic or cephalic vein of dominant arm


name: Position supine for insertion with arm at 90-degree angle to body


name: Secure catheter and apply sterile transparent dressing, per agency protocol


name: Verify catheter tip placement by ultrasound or x-ray examination, as appropriate and per agency protocol


name: Instruct on dressing change technique, as appropriate


name: Flush line after each use with appropriate solution per agency protocol


name: Maintain line patency according to agency protocol, as appropriate


name: Instruct about line flushes and medication administration techniques, as appropriate


name: Instruct to report signs of infection (e.g., fever, chills, drainage from insertion site)


name: Induce hypertension with volume expansion or inotropic or vasoconstrictive agents, as prescribed, to maintain hemodynamic parameters and maintain or optimize CPP


name: Monitor patient's PT and PTT to keep one to two times normal, as appropriate


name: Monitor for signs of fluid overload (e.g., rhonchi, JVD, edema, and increase in pulmonary secretions)


name: Identify behaviors that necessitate intervention (e.g., agitation, violence)


name: Provide distraction activities before use of restraints (e.g., television, visitors)


name: Explain procedure, purpose, and duration of intervention in understandable terms


name: Follow six rights of medication administration


name: Monitor sedation, agitation, and mental status using validated tools, as appropriate


name: Monitor vital signs (e.g., respiratory rate, oxygen saturation, temperature, blood pressure, end-tidal CO2 level)


name: Provide appropriate level of supervision or surveillance to allow for therapeutic actions, as needed


name: Provide physical, psychological, and psychosocial comfort, as needed


name: Provide for movement and exercise, according to level of self-control, condition, and abilities


name: Position for comfort, prevention of aspiration, and skin breakdown


name: Evaluate need for continued restrictive intervention at regular intervals


name: Involve person in making decisions to move to less restrictive form of intervention, when appropriate


name: Record response to medications per agency protocol


name: Encourage good oral hygiene with use of dental cleansing devices, such as unwaxed non-shredding floss, sonic toothbrushes, or water pics, as appropriate


name: Build trusting, therapeutic relationship with child and caregivers


name: Assist each child to become aware of importance as individual


name: Encourage shared decision making and self-care during illness and chronic disease management


name: Model activities that promote development to caregivers


name: Facilitate caregiver participation in child's care, as appropriate


name: Facilitate family-professional collaboration in child's care plan


name: Refer caregivers to support group for child and family, as appropriate


name: Ensure body language agrees with verbal communication


name: Provide opportunity for child to engage with peers, as appropriate


name: Create safe, well-defined space for child to explore and learn


name: Instruct how to seek help from others, when needed


name: Help child perform and master self-help skills (e.g., feeding, toileting, brushing teeth, washing hands, dressing)


name: Be consistent and structured with behavior management or modification strategies


name: Have misbehaving child "take breaks" or "time outs", as appropriate


name: Provide opportunity and materials for creative expression (e.g., building, drawing, clay modeling, painting, glue, cutting, coloring)


name: Provide opportunities to complete schoolwork or developmentally appropriate educational activities


name: Provide opportunities for and encourage exercise


name: Provide opportunity to play on playground, as appropriate


name: Assure that medical tests and treatments are done in timely manner, as appropriate


name: Provide honest, developmentally appropriate information


name: Review immunization status, reinforce importance, and administer as needed


name: Encourage oral hygiene using soft bristled toothbrush and pea sized amount of fluoridated toothpaste


name: Administer screening tools at regular intervals to evaluate child growth and development


name: Evaluate hearing and vision screenings annually


name: Perform comprehensive appraisal of peripheral circulation (i.e., check all peripheral pulses, edema, capillary refill, color, and temperature)


name: Conduct complete evaluation of clinical history and physical examination


name: Inspect skin for arterial ulcers or tissue breakdown, especially poorly healing or nonhealing wounds


name: Monitor degree of discomfort, fatigue, or pain with exercise or rest


name: Provide pain relief with analgesic agents, hanging foot over side of bed, or sleeping in chair, as appropriate


name: Evaluate leg symptoms with exertion, as may indicate claudication


name: Place extremity in dependent position, as appropriate


name: Administer statin therapy, antihypertensive, antiplatelet, or anticoagulant medications, as prescribed


name: Change position at least every 2 hours, as appropriate


name: Encourage consumption of healthy diet and weight loss, as appropriate


name: Evaluate presence of risk factors for arterial disease (e.g., advanced age, tobacco use, diabetes, smoking, dyslipidemia, hypertension, obesity, hyperhomocysteinemia)


name: Recommend smoking cessation, as appropriate


name: Protect extremity from injury (e.g., sheepskin under feet and lower legs, footboard or bed cradle at foot of bed, well-fitted shoes)


name: Protect extremities from cold, heat, and trauma


name: Monitor nutrition and fluid status, including intake and output


name: Implement gentle wound care and cleaning, as appropriate


name: Restore cutaneous blood flow in arterial ulcers, as appropriate, to control possible infections


name: Promote adequate oxygen delivery to wound


name: Instruct on factors that interfere with circulation (e.g., restrictive clothing, exposure to cold temperatures, crossing of legs and feet)


name: Determine peripheral circulation status (e.g., check peripheral pulses, edema, capillary refill, color, temperature)


name: Match device indications and contraindications to ensure device coincides with condition


name: Coordinate waveforms with inflation and deflation of device, as indicated


name: Observe for hemolysis (e.g., blood in urine, hemolyzed blood specimens, increase in daily serum hemoglobin, frank bleeding, hyperkalemia, kidney failure)


name: Administer anticoagulants or anti-thrombolytics, as prescribed


name: Monitor device regularly to ensure proper functioning (e.g., waveforms, alarm notes, catheter position information)


name: Ensure back-up equipment available at all times


name: Monitor vital signs and urine output every hour


name: Monitor, intake and output every hour, as prescribed


name: Monitor peripheral circulation every hour with femoral or axillary device placements


name: Administer prophylactic antibiotics as ordered


name: Collect blood, urine, sputum, and wound cultures if febrile, as prescribed


name: Plan for early ambulation with axillary device implantations


name: Provide education related to purpose and care of device


name: Use teach-back to determine understanding


name: Evaluate peripheral circulation (e.g., pulses, edema, capillary refill, color, temperature)


name: Review history of comorbidities (e.g., hypertension, heart failure, peripheral vascular disease, asthma, obstructive airway disease, inflammatory bowel disease, present or past history of cancer, anemia, malnutrition, lack of mobility)


name: Identify risk factors for venous ulcers (e.g., varicose veins, deep vein thrombosis, chronic venous insufficiency, poor calf muscle function, arteriovenous fistulae, obesity, history of leg fracture)


name: Consider diet modifications, nutritional supplements, smoking cessation, weight reduction, avoidance of immobility, and maintenance of healthy cardiac status, as appropriate


name: Examine physical, emotional, and lifestyle conditions that may contribute to venous stasis conditions


name: Determine ability to conduct preventative self-care measures, including consistent management of leg edema


name: Outline plan of care for self-care, using person and family input


name: Promote psychosocial, economic, and health care system support, as appropriate


name: Optimize local wound environment through cleansing, debriding, managing bacterial balance and managing moisture balance, as appropriate


name: Irrigate ulcers with warmed saline solution, as needed


name: Apply dressing appropriate for wound size and type, as indicated


name: Administer antiplatelet or anticoagulant medications, as prescribed


name: Protect affected extremity from injury (e.g., sheepskin under feet and lower legs, footboard or bed cradle at foot of bed, well-fitted shoes)


name: Monitor fluid and nutritional status, including intake and output


name: Monitor for signs of infection, cellulitis, deep vein thrombosis, and joint contractures


name: Implement pain relief measures (e.g., compression therapy, exercise, leg elevation, analgesia)


name: Apply compression therapy modalities (e.g., short-stretch or long-stretch bandages), as appropriate


name: Instruct to remove compression and seek advice if any side effects (e.g., numbness, tingling, pain, discolored toes)


name: Elevate affected limb 20 degrees or greater, to be higher than level of heart, as appropriate


name: Encourage passive or active range-of-motion exercises especially of lower extremities during bed rest


name: Encourage to remain active wearing some form of compression system


name: Instruct on importance of compression therapy, daily leg elevation and need for lifelong compression


name: Instruct regarding care and application of compression stockings, including need to replace stockings every 6 months if worn daily


name: Instruct to eliminate restrictive clothing, sit without legs crossed and avoid sitting or standing for long periods to reduce constriction of the blood vessels


name: Instruct regarding measures to prevent injury


name: Administer pain control approximately 1 hour before procedure (e.g., acetaminophen)


name: Position in comfortable position during procedure


name: Use padded circumcision seat for infants


name: Use radiant warmer to maintain body temperature during procedure


name: Use pacifier dipped in sucrose 24% during procedure and until next feeding with permission from parent or guardian, as indicated


name: Administer topical local analgesia agent (e.g., eutectic mixture of local anesthetics [EMLA]), as ordered


name: Assist with dorsal penile nerve block, as appropriate


name: Monitor for bleeding every 30 minutes for at least 2 hours post procedure


name: Provide postprocedure pain control every 4 to 6 hours for 24 hours (e.g., acetaminophen)


name: Instruct on signs and symptoms to report to health care provider (e.g., increased temperature, bleeding, swelling, inability to urinate)


name: Instruct to follow up in 3 to 5 days with health care provider


name: Instruct to apply dressing with each diaper change or after urinating until healing is complete or until plastic ring falls off, as indicated


name: Introduce self and ensure comfort, privacy, and confidentiality


name: Convey authenticity, warmth, genuineness, interest, and unconditional caring


name: Determine purpose, goals, and agenda for session


name: Develop and understand concerns, problems, and difficulties


name: Determine how problems may interfere with daily life


name: Identify what thoughts are associated with problem


name: Determine how long problem has persisted


name: Identify any pattern of events that may be associated with problem


name: Assist in accepting that self-statements mediate emotional arousal


name: Assist in understanding irrational self-statements cause inability to attain desirable behaviors


name: Assist in identifying styles of dysfunctional thinking (e.g., polarized thinking, overgeneralization, magnification, personalization)


name: Encourage identification and naming of painful emotions (e.g., anger, anxiety, hopelessness)


name: Assist in identifying perceived stressors (e.g., situations, events, interactions with other people) that contributed to stress


name: Assist to identify faulty interpretations about perceived stressors


name: Assist in recognizing irrationality of certain beliefs compared with actual reality


name: Assist in changing irrational self-statements to rational self-statements


name: Assist in replacing faulty interpretations with more reality-based interpretations of stressful situations, events, interactions


name: Apply therapeutic techniques and strategies to facilitate changing thought patterns (e.g., Socratic questioning, life event visualization, feeling focusing, summary and reframing, thought records, de-catastrophizing or "what if " technique, positive belief records)


name: Make statements and ask questions that challenge perception and behavior, as appropriate


name: Assist to identify belief system that affects health status


name: Use belief systems to see situation in a different way


name: Reinforce learning and use of new thought patterns


name: Evaluate for progress toward achieving desired goals


name: Prepare for ending of therapeutic session


name: Encourage the use of a multi-stimulation program (e.g., singing and listening to music, creative activities, exercise, conversation, social interactions, problem solving) to promote and protect cognitive capacity


name: Determine goals for management of environment and optimum comfort


name: Ease transition by warmly welcoming to new environment


name: Give consideration to placement of persons in multiple-bedded rooms (i.e., roommates with similar environmental concerns when possible)


name: Provide single room if preference and need for quiet and rest, if possible


name: Provide safe, clean, calm, and airy environment


name: Provide or remove blankets to regulate temperature, as indicated


name: Adjust lighting to meet needs of activities, avoiding direct light in eyes


name: Facilitate hygiene measures (e.g., wiping brow; applying skin creams; cleaning body, hair, and oral cavity)


name: Position to facilitate comfort (e.g., using principles of body alignment, support with pillows, support joints during movement, splint over incisions, immobilize painful body part)


name: Encourage non-pharmacological actions to increase comfort (e.g., music therapy, massage therapy)


name: Monitor skin, especially over bony prominences, for signs of pressure or irritation


name: Provide relevant and useful educational resources concerning management of illnesses and injuries


name: Analyze infection data routinely in healthcare settings and community to make evidence-based decisions


name: Identify individuals who are potentially contagious


name: Isolate potentially contagious individuals if indicated, quickly and appropriately


name: Require use of standard precautions with all person-to-person contact


name: Promote frequent handwashing or cleansing with antimicrobial hand sanitizer


name: Promote use of personal protective equipment (PPE) where indicated


name: Create triage areas in affected healthcare settings where isolation is possible, during known outbreaks


name: Create specific isolation areas for affected individuals during known outbreaks


name: Ensure provision of strengthened forms of support, including social and emotional support, to prevent adverse effects when source isolation or other forms of constraints are in use


name: Ensure community workers and at-risk health care workers receive relevant and up-to-date vaccinations


name: Ensure regular educational programs related to benefits of vaccinations within community


name: Encourage persons to avoid crowded settings during known outbreaks


name: Provide information related to respiratory hygiene and cough etiquette


name: Instruct persons to stay away from work or school when having active symptoms of infection


name: Promote use of disinfectants in institutions and schools


name: Use available technological advancements to monitor communicable diseases in communities (e.g., wastewater-based epidemiology, water fingerprinting)


name: Encourage proper prescribing and use of antibiotics to avoid superinfections


name: Provide information about antibiotic use and need to finish complete dosage, as prescribed


name: Promote access to adequate, regular health care treatment and health education related to prevention and treatment of communicable diseases and prevention of recurrence (e.g., safe sex practices, proper food handling, handwashing, avoidance of intravenous drug use)


name: Promote harm-reduction services for persons who inject drugs, such as medication-assisted treatment and syringe service programs (SSPs), to reduce risk of blood borne infectious disease acquisition (e.g., hepatitis C, HIV)


name: Ensure regular interactions with media to keep public properly informed of risks and proper actions to avoid spread of communicable diseases


name: Identify potential types of disasters for area (e.g., industrial, environmental)


name: Identify all community medical and social agency resources available to respond to disasters


name: Work with other agencies in planning for disasters (e.g., EMS services, local, state, and government agencies)


name: Build disaster leadership team with prearranged roles, adequate availability, and designated command center


name: Develop disaster notification network to alert personnel


name: Establish housing for personnel to remain on site if needed


name: Develop internal (e.g., place of business, home) and external (e.g., city, county, state) evacuation routes for various disaster scenarios (e.g., earthquake, hurricane, flood, terrorist)


name: Encourage regular review of internal and external evacuation routes throughout community


name: Encourage posting of evacuation plans in all buildings


name: Create shelters for displaced persons (e.g., bomb shelter, flood shelter) and signage to locate shelters


name: Check and restock shelter supplies routinely